InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
85.17
(
0.07%
)
Bitcoin
63,554.86
(
1.41%
)
Post# of 252443
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119956
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 118658

Sunday, 04/24/2011 9:44:42 PM

Sunday, April 24, 2011 9:44:42 PM

Post# of 252443
Re: BG-12 safety record

BIIB’s two fumaric-acid derivates—BG-12 and Fumaderm—are not identical. The difference is that Fumaderm* contains both dimethyl fumarate and monoethyl fumarate, while BG-12 contains dimethyl fumarate only. This distinction probably isn’t consequential from a safety standpoint, but I don’t think one can say for sure.

This post was prompted by an assertion on another board that BG-12 has a longstanding safety record, which is not quite correct.

*Approved in Germany for psoriasis.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up